GL1X · GenesisL1 explorer

Research workbench

Catalytic domain of mouse 2',3'-cyclic nucleotide 3'- phosphodiesterase, with mutation H230Q, complexed with citrate

Analyse Catalytic domain of mouse 2',3'-cyclic nucleotide 3'- phosphodiesterase, with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4WCA
Type
protein
Length
207 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
2',3'-cyclic-nucleotide 3'-phosphodiesterase
EC
3.1.4.37
UniProt
P16330
Ligands
CL
Pockets
2 · best druggability 0.60

Structure

x-ray diffraction · 1 distinct chain · 33% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A2',3'-cyclic-nucleotide 3'-phosphodiesterase (EC 3.1.4.37)protein20733% helix, 32% strandP16330

Ligands and binding sites

  • CL · Chloride ion · ion · chains A
  • 1PE · Pentaethylene glycol · additive · 6 copies · chains A
  • CIT · Citric acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12900.600.7838CIT, 1PE
2660.370.78151PE

Modifications

Observed in the structure: 1 modified (oxidation).

Compared structures

  • 4WCA · Catalytic domain of mouse 2',3'-cyclic nucleotide 3'- phosphodiesterase, with mutation… · the same entry in another collection · chain A against A, TM-score 1.00
  • P16330 · AlphaFold monomer V2.0 prediction for 2',3'-cyclic-nucleotide 3'-phosphodiesterase… · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.